About
RVL Pharmaceuticals develops and commercializes prescription ophthalmic products and skincare solutions focused on ocular vitality and aesthetic innovation, including the FDA-approved product Upneeq® for acquired blepharoptosis.
Explore RVL Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.